Steel Partners Holdings LP has made an offer to acquire a majority stake in InMode Ltd., a company specializing in minimally invasive aesthetic devices. The offer values InMode at $18 per share. This move signals potential consolidation within the burgeoning medical aesthetics market, a sector that has seen considerable growth in recent years.

The bid targets 51% of InMode, indicating Steel Partners' desire for significant control and influence over the company's strategic direction. InMode manufactures devices for body treatments, a market segment that has demonstrated resilience and expansion. Investors will be watching to see how this deal impacts InMode's stock price and future operations.

The medical aesthetics industry is competitive, with companies constantly innovating to meet consumer demands for non-invasive procedures. Any successful acquisition could reshape the competitive arena. The next step is a response from the InMode board, which will determine whether to accept, reject, or negotiate the offer.

What's next for InMode? The market will be watching to see if this deal is successful. The board of directors will have a tough decision to make. If approved, the deal could drive further mergers and acquisitions in the industry, as other companies look to expand their market share.